Revivent
 | This article, Revivent, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Revivent-TC is a medical device used for patients with impaired left ventricle.[1] The device is used to treat heart failure due to ischemic cardiomyopathy (ICM) with left ventricular aneurysm, and studies have shown it helps in the modification of left ventricular geometry and function.[2][3] The device is employed to construct the left ventricular without incisions in the myocardium.[4] The first in-human procedures of the Revivent-TC trial were performed in September 2013.[5][6]
Methodology
The Revivent-TC device is used by applying a pair of anchors, such as articulating polyester covered titanium anchors mounted on a polyesthylene-ether-etherketone tether. The procedure can achieve plication between the anterior and septal wall regions to reduce the left ventricular cavity area. Usually, three to five pairs of the Revivent-TC systems are implanted to complete the planned procedure.[5]
References
- ^ Kitamura M (February 2018). "Heart Failure Interventions Targeting Impaired Left Ventricles in Structural Heart Disease". Current Cardiology Reports. 20 (8): 7. doi:10.1007/s11886-018-0950-6. PMID 29435772.
- ^ Kitamura M (February 2018). "Heart Failure Interventions Targeting Impaired Left Ventricles in Structural Heart Disease". Current Cardiology Reports. 20 (8): 8. doi:10.1007/s11886-018-0950-6. PMID 29435772.
- ^ Wechsler, A (September 2013). "Durability of epicardial ventricular restoration without ventriculotomy". European Journal of Cardiothoracic Surgery. 44 (3): 189–92.
- ^ Kitamura M (February 2018). "Heart Failure Interventions Targeting Impaired Left Ventricles in Structural Heart Disease". Current Cardiology Reports. 20 (8): 3. doi:10.1007/s11886-018-0950-6. PMID 29435772.
- ^ a b Kitamura M (February 2018). "Heart Failure Interventions Targeting Impaired Left Ventricles in Structural Heart Disease". Current Cardiology Reports. 20 (8): 4. doi:10.1007/s11886-018-0950-6. PMID 29435772.
- ^ Zivelonghi C, et al. (March 2018). "Hybrid Transcatheter Left Ventricular Reconstruction for the Treatment of Ischemic Cardiomyopathy". Journal of Euro PCR EuroIntervention. 13 (16): 1899–1901. doi:10.4244/EIJ-D-17-00413. PMID 28966158.
Category:Interventional cardiology Category:Medical devices Category:Valvular heart disease
| This article, Revivent, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |